---
layout: post
title: "Recombinant zoster vaccine is associated with a reduced risk of dementia."
author: "Habakuk Hain"
categories: transmission
tags: ["recombinant zoster vaccine", "dementia prevention", "neuroinflammation"]
image:
rating: 8
paper_title: "Recombinant zoster vaccine is associated with a reduced risk of dementia."
paper_author: "Rayens"
paper_journal: "Nat Comm"
paper_year: "2026"
paper_doi: "https://doi.org/10.1038/s41467-026-69289-0"
paper_et_al: true
summary: "Large retrospective cohort study of 329,000 adults â‰¥65 years found that two-dose recombinant zoster vaccine (RZV) was associated with a 51% reduction in dementia risk over follow-up. The association remained significant (27% risk reduction) even after controlling for healthy vaccinee bias using Tdap vaccination as a comparator."
author_context: "Kaiser Permanente Southern California Department of Research & Evaluation with GSK collaboration - robust epidemiological research infrastructure"
---

**Problem**: Whether recombinant zoster vaccine specifically reduces dementia risk, building on prior observations with live zoster vaccine.

**Result**: RZV vaccination showed a statistically significant 51% reduction in dementia risk (aHR 0.49), with 27% reduction persisting after controlling for healthy vaccinee bias.

**Open Questions**: The mechanistic basis for this protective effect remains unclear, whether through direct neuroprotection, reduced neuroinflammation, or prevention of subclinical reactivations.
